Emily Aaronson, MD is a Patient Safety and Quality clinical fellow in the Massachusetts General Hospital Department of Emergency Medicine. She recently completed a year as a Chief Resident in the Harvard Affiliated Emergency Medicine Residency Program at Brigham & Women’s Hospital/Massachusetts General Hospital. Before medical school, Dr. Aaronson worked for H*Works on the consulting arm of the Advisory Board Company. She received her BA from George Washington University, and her MD from McMaster University, Michael G. DeGroote School of Medicine in Ontario. She has conducted grant funded research and published on quality in emergency care. Among her work on several Brigham and Massachusetts General Hospital committees, she served as a co-chair for the Housestaff Patient Safety and Quality Committee at Brigham & Women’s Hospital. As a resident, Dr. Aaronson spearheaded a departmental process improvement project centered on patient engagement in the Emergency Department, and worked with hospitals in Haiti and Ghana on quality improvement projects. As a fellow, she is focusing on work in improvements in Sepsis Care, Patient Engagement and mitigating safety risks in the Emergency Department.
Aalok Agarwala collaborates on the Operating Room Black Box project with Ariadne Labs to test new ways of gathering patient data and environmental information to reduce errors, improve quality, and better understand team dynamics in the operating room. This project will be piloted at Massachusetts General Hospital. Dr. Agarwala also collaborates with Ariadne Labs and the Emergency Manual Implementation Collaborative in the national effort to increase implementation of the Operating Room Crisis Checklist.
Dominique Arce’s research interests are related to the care of high-risk obstetrics patients, maternal-fetal outcomes, and delivery of safe anesthesia and analgesia in the obstetric population. Her current projects focus on intrapartum fever and its relationship to epidural analgesia for labor and exposure to environmental chemicals, along with their effects on maternal and neonatal adverse outcomes.
Stan Ashley, MD, serves as a member of a task force focused on reducing patient safety risk from health systems expansion. This task force is led by CRICO and convened by Ariadne Labs.
Michael Barnett is a primary care physician and health services researcher. His research focuses on the quality of health care delivery with particular interests in the primary-specialty care interface, low-value care, and innovations in health care delivery.
Salma Batool-Anwar’s research focuses on integrating palliative care services for critically ill patients in intensive care units. In addition, she is interested in studying the public health impact of variety of sleep disorders.
Amy Baughman, in her role as Director of Quality Improvement for the Geriatrics and Extended Care Service at Veteran Affairs (VA) Boston, utilizes her clinical research training in systems redesign and quality improvement. Her work focuses on patient flow, care transitions, and medication reconciliation between hospital and sub-acute care facilities at the VA Boston. She seeks collaboration in the quality improvement space and hopes to facilitate other collaborations between Ariadne Labs and the VA Boston.
Benjamin Bearnot is a Massachusetts General Hospital-trained physician-investigator looking for opportunities in health system innovation and implementation science. He enjoys employing existing methods, and developing new ones, to improve the health of communities through adaptive execution of evidence-based interventions. He is particularly passionate about transforming care for patients with opioid addiction and other substance use disorders, who suffer similar stigma to HIV-infected populations he worked with in New York City and Durban, South Africa previously. He now practices internal medicine at the Massachusetts General Hospital Charlestown community health center, attends on the addiction consult service at Massachusetts General Hospital, and is participating in innovation and community health leadership fellowships.
Rebecca Berger is an attending physician in the Hospital Medicine Unit at Massachusetts General Hospital. From 2016-2017, she was an editorial fellow at the New England Journal of Medicine. Her interests include quality improvement, patient safety, process improvement, and medical education.
Peter Berman is a Professor of the Practice of Global Health Systems and Economics at the Harvard T.H. Chan School of Public Health with more than 40 years of experience in research, policy analysis and development, and training and education in global health. Dr. Berman is also the visiting professor at the Public Health Foundation of India and advisor to the China National Health Development Research Center for health care financing and health accounts. Currently, Dr. Berman leads several innovative projects on developing primary care systems, strengthening service delivery, health system reform, and improving health care financing mechanisms for better outcomes, with a focus on work in Ethiopia, India, and Malaysia. Current projects include: RTM, HEPCAPS, and Fenot. He is co-coordinator with Professor Viswanath of Harvard T.H. Chan School of Public Health’s India Health Partnership. Dr. Berman has attended three of Primary Health Care Performance Initiative’s expert convenings.
Rachelle Bernacki leads the Serious Illness Community of Practice and serves as the faculty development lead in the Serious Illness, Vital Talk, and Center to Advance Palliative Care collaborative program. This program will nationally scale communication, implementation, and training efforts in order to strengthen health systems with innovative and comprehensive solutions in serious illness care that have a sustained impact. She is also the Project Director for the Dana-Farber Cancer Institute randomized controlled trial and the integrated Care Management Program, which focuses on high-risk primary care patients. She plays a key role at Ariadne Labs in the development, implementation and evaluation of a standardized approach for promoting clinicians to conduct discussions about end-of-life values and goals with seriously ill patients and their families. Dr. Bernacki was named a Cambia Sojourns Leadership Scholar in 2015.
William Berry serves as the Chief Medical Officer at Ariadne Labs where he oversees the growth and development for all research work including the program teams and platforms: Safe Surgery, Childbirth, Serious Illness Care, Primary Health Care, Informatics and Measurement, Implementation and Improvement Sciences, and Program Management. Dr. Berry is also the Director of the Safe Surgery Program where he oversees the program’s efforts to standardize safety measures in operating rooms.
Amy Billett is the Principal Investigator of a project through Ariadne Labs called “Making It Easier to Care for Your Central Line at Home: A Standardized Process to Reduce Ambulatory Central Line Associated Bloodstream Infections (CLABSI).” This project is developing a model to decrease infection rates in pediatric hematology/oncology patients by ensuring that patients and their families develop the confidence and skills to perform best practice central line care at home correctly, every time with decreased distress. Preliminary results demonstrate that the project is feasible and well received by families, and suggest a decrease in infection rates. The team is now seeking to apply this model to high risk medication administration in the home.
Asaf Bitton is a practicing primary care physician and assistant professor of medicine and health care policy at Harvard Medical School and Brigham & Women’s Hospital. He leads Ariadne Labs’ work around measuring and improving primary care performance as part of the Primary Health Care Performance Initiative (PHCPI), a joint effort with the Bill and Melinda Gates Foundation, The World Bank, The Results for Development Institute, and Ariadne Labs. Dr. Bitton is also Senior Advisor for the Comprehensive Primary Care Initiative Center for Medicare and Medicaid Innovation in Washington, DC.
Susan Block is a Senior Consultant to the Serious Illness Care Program at Ariadne Labs, a joint center for health care innovation at Brigham & Women’s Hospital and Harvard T.H. Chan School of Public Health and Professor of Psychiatry and Medicine at Harvard Medical School. She founded the program in 2011, and served as its Director until 2017. In addition, She was the Founding Chair of the Department of Psychosocial Oncology and Palliative Care at Dana-Farber Cancer Institute and Brigham & Women’s Hospital, and Founding Co-Director of the Harvard Medical School Center for Palliative Care, a program she and her husband, Andy Billings led for 17 years. Dr. Block received her AB from Stanford University, her MD from Case Western Reserve University School of Medicine, and completed residencies in both internal medicine and psychiatry at Beth Israel Deaconess Medical Center in Boston. She is board-certified in both fields. Dr. Block has been a national leader in the development of the field of palliative medicine, has led major innovative educational and quality improvement projects in a variety of areas, is known internationally as an expert in medical education, faculty development, and health system change, and has contributed to research in medical education, palliative care, psychooncology, and health system change. She is the author of over 200 publications and has won numerous awards for education, research and leadership.
Richard Cash’s research interests include scaling health programs. He conducted clinical trials of oral rehydration therapy on adults and pediatric cholera patients and interventions to scale up programs especially in diarrhea management. Dr. Cash has also developed programs to assist low and middle income countries’ scientists in honing their research skills and directs a program and workshops on research ethics.
Avik Chatterjee’s research interests include the impact of schools and education on health outcomes and cultural and linguistic competency in health care. He is looking forward to learning from colleagues at Ariadne Labs and building collaborations around addressing social determinants of health in low income communities in a systematic way.
Alyna Chien’s area of research expertise is in the relationship between the structure of the health care system, the incentives and price information that doctors and patients face, and resulting health care quality and spending, particularly for vulnerable populations. Her work has shown that incentives can improve preventive and chronic disease care for adult and pediatric patients in mixed and low-income populations. Dr. Chien’s current projects include examining the structure of large health care organizations and the quality of pediatric health care they provide, understanding spending variation for “shoppable” conditions (childbirth, breast cancer and prostate cancer), understanding how medical providers respond to patient’s social needs, and describing care quality and spending among children with disabilities.
James Colbert is lead author of the white paper, “Adopting Accountable Care: An Implementation Guide for Physician Practices,” and presented his work at Ariadne Labs’ Innovation meeting. In 2015, he was named by MedTech Boston one of 40 Healthcare Innovators under age 40.
Zara Cooper is a member of the Serious Illness Care Program at Ariadne Labs. Her work examines the intersection of acute surgery and end-of-life care with a goal to develop and evaluate a standardized approach for promoting clinicians to conduct discussions about end-of-life values and goals with seriously ill patients and their families.
Gregory Curfman is currently editor in chief of Harvard Health Publications at Harvard Medical School. Previously, he was executive director of the New England Journal of Medicine (NEJM), a position he held for 14 years. In his tenure at NEJM, he founded and currently directed the Perspective section, which focuses on issues at the interface of medicine and society. His work at NEJM played a critical role in driving the national dialogue on health care. A board-certified internal medicine physician and cardiologist, Dr. Curfman is also an assistant professor of medicine at Harvard Medical School. He graduated magna cum laude from Princeton University and received an MD cum laude from Harvard Medical School. Dr. Curfman has previously served as the director of the coronary care programs at the Brigham & Women’s Hospital and Dartmouth-Hitchcock Medical Center, and was also medical director at the Cardiovascular Health Center at Massachusetts General Hospital.
Nic Encina is a cross-discipline specialist who has played key roles in building teams and pioneering innovation at technology and pharmaceutical companies. He has almost two decades of front line operating experience, managing profit and loss statements, digital marketing, branding, corporate strategy, business development, innovation leadership, and strategic alliances. Most recently, at the discretion of PerkinElmer’s CEO, Nic drove a new approach to innovation by establishing a new semi-secret innovation lab and by helping the company define and implement its cloud and IOT strategies. Nic is passionate about product innovation and market disruption with a fierce bias toward execution. He is comfortable operating in environments where uncertainty is common, and particularly where the science of running a company intersects with the art of harnessing value from teams, ideas, and market opportunities.
Angela Feraco’s research seeks to enhance communication between providers and families early in the illness trajectory of childhood cancer. Informed by Ariadne Labs’ Serious Illness Care Program, Dr. Feraco is conducting a mixed-methods pilot feasibility study of the “Day 100 Talk,” which aims to ameliorate existing communication gaps during the early cancer treatment period through the creation of a focused interdisciplinary communication occasion guided by a structured conversation tool.
Shira Fischer’s research for the RAND Corporation focuses on health information technology research and policy. Her current work includes data integration of housing and medical for patients with HIV; family planning data collection in low-resource settings; and using health information technology to improve medication safety. She is also interested in data visualization of health data for both patients and providers. Dr. Fischer holds an MD and a PhD in Clinical and Population Health Research and completed a clinical informatics fellowship at Beth Israel Deaconess Medical Center and Harvard Medical School.
Erik Fromme specializes in palliative medicine and conducts research on managing the symptoms of cancer. He started the first supportive oncology and palliative medicine clinic in Oregon, where he works with nurses, social workers, and physical therapists to help patients with cancer and their families to control their symptoms and maximize the quality of their lives. Dr. Fromme specializes in managing cancer pain and other difficult symptoms such as nausea, tiredness, appetite loss, and sleeplessness. The clinic is available to patients at any stage of illness and treatment. Dr. Fromme received his MD from the University of Oklahoma Health Sciences Center and completed his residency at Oregon Health & Science University. He also completed fellowships in General Medicine at Johns Hopkins University, and Palliative Medicine and Pastoral Care at Massachusetts General Hospital. He is board certified in Internal Medicine and Hospice and Palliative Medicine.
Ishani Ganguli received her AB, MD, and MPH from Harvard University. She trained in Internal Medicine/Primary Care and completed fellowship in health policy and management at Massachusetts General Hospital. During fellowship, she led hospital-wide initiatives on patient education and patient-reported outcome measures while practicing primary care at the Massachusetts General Hospital Ambulatory Practice of the Future. She has since joined the faculty at Brigham & Women’s Hospital and Harvard Medical School – here, she studies health policy and practices at Brigham’s Advanced Primary Care Associates. Ishani is also a journalist who has written about science and health care for The Boston Globe, Reuters, The New York Times, and The Washington Post, among other publications. She is interested in how health policy, care delivery, and the media shape patient and clinician decision-making and, in turn, the costs and quality of health care.
Atul Gawande is the Executive Director of Ariadne Labs. He is also a surgeon, professor, writer, and public health researcher. He practices general and endocrine surgery at Brigham and Women’s Hospital, is professor in the Department of Health Policy and Management at the Harvard T. H. Chan School of Public Health, and Samuel O. Thier Professor of Surgery at Harvard Medical School. Atul is also Chairman of Lifebox, a nonprofit reducing surgical deaths globally.
An influential writer, Atul has been a staff writer for The New Yorker magazine since 1998 and has written four New York Times bestselling books: Complications, which was a finalist for the National Book Award in 2002; Better, which was selected as one of the 10 best books of 2007 by Amazon.com; The Checklist Manifesto in 2009, and Being Mortal in 2014. He has received numerous awards including two National Magazine Awards, Academy Health’s Impact Award for highest research impact on health care, a MacArthur Genius Award, and the Lewis Thomas Award for writing and science.
Atul earned a BAS from Stanford University, an MA in philosophy, politics, and economics from Balliol College at Oxford University, an MD from Harvard Medical School, and an MPH from the Harvard School of Public Health.
Richard Gitomer is a board certified general internist. Dr. Gitomer received his medical degree from Emory University, and completed residency and fellowship in internal medicine at Emory University Affiliated Hospitals. Following fellowship, Dr. Gitomer started his own primary care practice in Atlanta and joined the Emory Clinic in 1992. After 24 years at the Emory Clinic, Dr. Gitomer moved to Boston to accept the directorship of Brigham & Women’s Primary Care Center of Excellence.
Donald Goldmann focuses on deepening the credibility of improvement science and expanding its boundaries by incorporating methods from other related disciplines. He has performed studies across the entire continuum of translational research. He explores innovative ways to teach and learn and is lead faculty for the HarvardX/IHI MOOC on Practical Improvement Science. He is senior mentor for IHI’s Fellowship Programs and continues to mentor emerging investigators at Harvard, enabled by Federal T32 Pediatric Health Services Research Training Grants. He advocates for closer integration of improvement science and technology, with the goal of accelerating progress towards equity and population health. He serves on the AHRQ NAC and the Boards of AcademyHealth and the Institute for Medicaid Innovation. He is a Professor of Immunology and Infectious Diseases, and Epidemiology at the Harvard T.H. Chan School of Public Health, and Clinical Professor of Pediatrics at Harvard Medical School.
Susan Haas is co-PI for Ariadne Labs’ CRICO-funded work focused on reducing health care system expansion risks to patient safety. She oversees the planning and execution of the expansion risks work to design and test tools to be used prior to (elucidating the risks) and after affiliation ( prioritizing and mitigating the risks).
Joaquim Havens is investigating the burden of emergency general surgery in the United States. He has developed and is currently testing the use of an Emergency General Surgery checklist and intra-operative huddle under a grant from CRICO in collaboration with Ariadne Labs’ Chief Medical Officer, Dr. Bill Berry.
Alex Haynes’ research focuses on improving surgical care delivery through measurement and implementation of quality improvement initiatives. His work bridges environments as diverse as acute care hospitals in South Carolina, where he has been involved in the Safe Surgery 2015 collaborative, to ambulatory surgery centers across the country, as well as hospitals and health systems around the globe. He recently led efforts to report the outcomes of the Safe Surgery 2015 program, finding a significant reduction in postoperative mortality from inpatient surgery paralleling changes in teamwork and communication in the operating rooms. In collaboration with colleagues from the Harvard Business School, Dr. Haynes is running a study to investigate the links between hospital management practices and quality of clinical care, including the ability to implement large-scale quality improvement projects, funded with a research grant from the Rx Foundation. He has also recently launched a collaboration with Dr. JP Onnela of the Harvard T.H. Chan School of Public Health to harness smartphone technology to better understand how surgery affects patient centered outcomes, including physical, emotional, and social well-being. This work will result in methods to measure and assess surgical care, as well as tools for counseling patients and monitoring outcomes outside of the clinical environment.
Dan Henderson is a generalist physician with a passion for leading system improvement. As a Clinical Innovation Fellow and primary care physician at the Massachusetts General Hospital, Dr. Henderson works on redesigning care processes and IT systems around high-risk moments, including transitions from hospital to home and medication prescribing.
Natalie Henrich is the Associate Director of the Science & Technology Platform at Ariadne Labs. In this role, Natalie collaborates with project teams to promote high quality science in all phases of their work. She is also involved in supporting, strengthening, and increasing awareness of science and evaluation across the organization. Prior to joining Ariadne Labs, Natalie was a research scientist and program evaluator at the Center for Health Evaluation and Outcome Sciences in Vancouver, Canada.
David Hepner is a co-investigator on the Ariadne Labs Agency for Health Care Research and Quality Crisis Checklist project. He also serves on the Emergency Manuals Implementation Collaborative Steering Committee with Ariadne Labs.
Joe Jacobson is the Chief Quality Officer at Dana-Farber Cancer Institute (DFCI) and an Associate Professor of Medicine at Harvard Medical School. He is board certified in Internal Medicine, Medical Oncology and Hematology and holds a Masters in Science in Epidemiology. His role at DFCI is to oversee the quality of care on the main campus and network locations. Over the last decade, he has helped initiate and lead a variety of quality-focused projects, committees and teams. He was among the founding members of the American Society of Clinical Oncology’s “Quality Oncology Practice Initiative.” He co-leads the Partners Clinical Process Improvement Leadership Program and lectures broadly on quality and patient safety.
Joseph Jacobson is a co-SPARK grantee of Ariadne Labs with Associate Faculty member Dr. Lipika Samal. They are researching how health information technology (HIT) could help oncologists improve diagnosis and treatment for cancer patients by closing the “knowing-doing gap.” Their team aims to design a HIT tool that will help oncologists to better use existing data when making decisions. The focus is on solid tumor cases where at least two specialties are involved in palliation or treatment planning.
Ravi Kavasery collaborates with the Primary Health Care Performance Initiative in their advisory role to the World Bank engagement with the Estonian Health Insurance Fund. The goal of this work is to improve care transitions, reduce fragmentation of care, and develop an algorithm to identify patients at high risk for poor outcomes based on their history of care utilization, health indicators, and social and behavioral risk factors. As part of this collaboration, Dr. Kavasery has also helped train providers in Estonia on building successful teams and promoting patient empowerment in primary care.
Ramin Khorasani’s current research focuses on use of innovative health IT tools, quality improvement methodologies and change management strategies to improve quality, safety and efficiency of health care care. He published a paper with Dr. Atul Gawande titled “Use of Public Data to Target Variation in Providers’ Use of CT and MR Imaging among Medicare Beneficiaries.” He also presented a talk at an Ariadne Labs’ Innovation meeting titled “Health IT enabled evidence-based practice: Gains, Gaps, and Opportunities.”
Joshua Lakin serves as the clinical lead for the Serious Illness Care Program at Brigham & Women’s Hospital, both in primary care and general inpatient medicine settings. His recent research focuses on the implementation of the program in primary care. He plays a key role in the Serious Illness Care Program at Ariadne Labs to develop and evaluate a standardized approach for promoting clinicians to conduct discussions about end-of-life values and goals with seriously ill patients and their families.
Biography coming soon.
Daniela Lamas served as the Clinical Lead for the Spaulding Rehabilitation Hospital pilot project testing the acceptability and feasibility of the use of the Serious Illness Care Conversation Guide with chronically critically ill patients and their surrogates. She plays a key role in the Serious Illness Care Program at Ariadne Labs to develop and evaluate a standardized approach for promoting clinicians to conduct discussions about end-of-life values and goals with seriously ill patients and their families. She also works on clinical and research projects aiming to better understand and improve outcomes for patients who have survived critical illness.
Kimberlyn Leary’s research interests include delineating the components of effective leadership and the interpersonal exchanges that promote change and collaborative decision-making. She also studies the factors that improve health and life outcomes for women and girls, including women and girls of color.
Lisa Lehmann is a primary care physician and bioethicist. In addition to her position as the National Center for Ethics in Health Care’s (NCEHC) Executive Director, she is an Associate Professor of Medicine and Medical Ethics at Harvard Medical School and Associate Professor of Health Policy and Management at the Harvard T.H. Chan School of Public Health. Prior to joining NCEHC, Dr. Lehmann practiced primary care and was Director of Bioethics at Brigham & Women’s Hospital. There, she helped develop a robust clinical ethics consultation service and a strong program in ethics education for trainees and hospital staff, developed hospital ethics policy, taught and mentored medical and graduate students, and had an active program of grant-funded empirical and normative research in bioethics. Her research focuses on how to improve care for patients and families at the end of life, the relationship between moral courage, speaking up and patient safety, how to responsibly integrate genomics into clinical medicine, and the intersection of ethics and health policy. Dr. Lehmann was Chair of the Society of General Internal Medicine Ethics Committee, Chair of the Framingham Heart Study Ethics Advisory Board, and Chair of the Harvard Medical School Scholars in Medicine Medical Humanities Advisory Committee. She is a member of the American College of Physicians Ethics, Professionalism and Human Rights Committee.
David Levine is a practicing general internist and investigator at Brigham & Women’s Hospital and Harvard Medical School. His research focuses on digital health, care redesign, and the quality of delivered health care. He believes fast iterative design grounded in robust research methodology yields results. Among other projects, his team runs a home hospital randomized controlled trial to bring acute care to acutely ill adults as a substitute for traditional hospitalization. They are deploying remote wireless monitoring, predictive analytics, and high-touch care in the home.
Stuart Lipsitz is a biostatistician at Ariadne Labs, and is heavily involved in virtually all programs and research at Ariadne Labs. His specialty is advanced statistical methods, and he has developed new techniques that are widely used in studies with missing data, repeated measures studies, and complex sample surveys.
Ernest Mandel serves as the Clinical Lead for the Dana-Farber Cancer Institute-Brigham & Women’s Faulkner Hospital project studying the adaptability and feasibility of integrating the Serious Illness Care Program into a busy dialysis center. He plays a key role in the Serious Illness Care Program at Ariadne Labs to develop and evaluate a standardized approach for clinicians to conduct discussions about end-of-life goals and preferences with seriously ill patients and their families.
Kenneth Mandl works at the intersection of population and individual health with a focus on biomedical informatics. He received a Presidential Early Career Award for Scientists and Engineers for pioneering real time biosurveillance, tracking infections, and detecting outbreaks with diverse data. Dr. Mandl developed SMART, a widely adopted, highly influential approach, to enabling substitutable iPhone-like apps that run universally on health IT systems. He most recently presented his work in a talk entitled “Building the App Store for Public Health: A Perfect Storm” at an Ariadne Labs’ Innovation meeting.
Duncan Maru collaborates on grants and implementation research methodologies with Ariadne staff and faculty. He is the co-founder, chief strategy officer, and a board member of Possible, a non-profit health care company that delivers high-quality, affordable health care in rural Nepal on a public-private partnership model. Possible’s staff of approximately 250 cares for over 130,000 patients per year. Dr. Maru oversees the vision and execution of Possible’s work in government partnerships, impact evaluation, and implementation science. Possible has deployed an open-source electronic medical record (EMR) that integrates care from community health care workers to clinics and hospitals. Through this EMR, Possible aims to implement quality improvement practices, perform surveillance, and conduct rapid, low-cost randomized evaluations of delivery innovations.
Kate Miller supports quantitative research designs, statistical analyses, and mixed-methods approaches across Ariadne’s research portfolio, including the Better Birth, Serious Illness, and Primary Health Care initiatives. Dr. Miller’s interests include innovative research designs, implementation science, quality of care, and women’s health.
Rose Molina is a board-certified obstetrician/gynecologist at The Dimock Center and Beth Israel Deaconess Medical Center, and an Instructor in Obstetrics, Gynecology and Reproductive Biology at Harvard Medical School. She completed the Global Women’s Health Fellowship at Brigham & Women’s Hospital and obtained a Master of Public Health in Clinical Effectiveness from the Harvard T.H. Chan School of Public Health. Dr. Molina works as a Women’s Health Advisor for Partners In Health/Compañeros En Salud in Chiapas, Mexico, an organization she has worked with since 2008. Dr. Molina also works with the Delivery Decisions Initiative at Ariadne Labs to design, test and spread a solution to optimize cesarean delivery rates and ensure that every woman receives appropriate and safe care during childbirth. Her current work focuses on improving shared decision-making in prenatal and obstetric care for Spanish-speaking women. Her advocacy interest is improving access to health care for undocumented immigrants in the United States.
Matthew Mossanen is a urologist at Brigham & Women’s Hospital and Massachusetts General Hospital. Dr. Mossanen received his MD from the David Geffen School of Medicine at the University of California Los Angeles and completed his residency in urology at the University of Washington Medical Center. His research interests involve the quality of, access to, and delivery of cancer care. He received a Partners in Health Policy Grant to support a project that attempts to create a cost-effective, easily scalable program to help cancer patients, especially the elderly and frail, prepare for morbid operations. He supports the use of checklists in the pre-operative period to help cancer patients, caregivers, and providers by focusing on high-yield tasks. Dr. Mossanen is interested in improving the quality of care provided to cancer patients in the US and abroad.
Ed Nardell is a professor in the Departments of Medicine and of Global Health and Social Medicine at Harvard Medical School and an associate professor in the Departments of Immunology and Infectious Diseases and of Environmental Health at the Harvard T.H. Chan School of Public Health. He is an associate in medicine in the Department of Medicine at Brigham & Women’s Hospital, in both the Division of Global Health Equity and the Pulmonary Division. His research interests involve the control of tuberculosis under resource-limited conditions, with a focus on the pathogenesis of drug-resistant tuberculosis, its airborne transmission, and transmission control in institutions. Another long-standing research avenue is the application of germicidal irradiation to reduce airborne transmission. Dr. Nardell also is developing more efficient, less expensive ultraviolet germicidal irradiation fixtures for resource-limited settings. In addition, he has worked on developing and validating a computer-assisted design software package to facilitate planning of UV installations in buildings. He has also begun testing a novel, environmentally safe chemical vapor that may be effective in reducing airborne transmission.
Kitty O’Hare is the Assistant Program Director for the Brigham & Women’s Hospital/Boston Children’s Hospital Medicine-Pediatrics Residency. In addition, Dr. O’Hare serves as the Director of Transition Medicine for Primary Care at Boston Children’s Hospital. She provides outpatient transition consultations and is a co-founder of the Weitzman Family BRIDGES Adult Transition Program. Dr. O’Hare is a staff physician at Brigham & Women’s Family Care Associates where she provides primary care to children and adults. Dr. O’Hare’s primary interests include transitions from pediatric to adult care, children with special health care needs, and primary care quality improvement. She is passionate about partnering with families to make young adult transitions less stressful for everyone. Dr. O’Hare believes that community engagement and effective health policies are important for maintaining the health of our patients. She also believes it is vitally important to educate the future generation of physicians and health care leaders to care for our growing population of young adults with chronic health conditions.
JP Onnela’s research focuses on statistical analysis and mathematical and computational modeling of social and biological networks and their connection to human health. His other main research area is digital phenotyping. Prior to joining the Department of Biostatistics at the Harvard T.H. Chan School of Public Health in November 2011, he was a Postdoctoral Research Fellow at Harvard Medical School, a Fulbright Visiting Scholar at the Harvard Kennedy School, and a Junior Research Fellow at Oxford University. He obtained his doctorate at the Helsinki University of Technology in 2006. He received National Institute of Health Director’s New Innovator Award in 2013.
Kei Ouchi, as a practicing emergency physician, is passionate about providing goal-concordant care to older adults with serious illness in the emergency department. As an associate faculty a part of the Serious Illness Care Program at Ariadne Labs, he believes in the emergency department’s potential role to serve as the screening point for such patients and align their preferences to the care they receive towards the end of life. Dr. Ouchi is currently developing and testing a screening strategy to identify such patients and facilitate their advanced care planning process during or after their emergency department visit.
Erika Pabo works on transforming the health care system to better meet the needs of individual patients and populations at a cost that is sustainable to society over time. She specifically focuses on primary care growth, operations improvement, care delivery redesign, and virtual care delivery.
Joanna (Jo) Paladino is a palliative care physician, implementation specialist, educator, and researcher. She currently serves as the Associate Director of Implementation for the Serious Illness Care Program at Ariadne Labs. The serious illness care team has developed an evidence-based program that includes communication tools, clinician training, and systems changes. Jo’s research in a randomized controlled trial in oncology demonstrates that the program leads to more, earlier, and better conversations and significant improvements in patient well-being. To translate this research into measurable improvements in care on a broad scale, Jo has developed an implementation model that she and her team are expanding to health care systems throughout the country. She is also one of a small group of expert faculty educators and has trained hundreds of clinicians to have compassionate and effective serious illness conversations with their patients. Jo earned her MD from Weill Medical College of Cornell University and is board certified in internal medicine and palliative care. She lives with her husband Savan in Boston, Massachusetts.
Andrea Farkas Patenaude a clinical and research psychologist at the Dana-Farber Cancer Institute where she is the director of Psycho-Oncology Research in the Division of Pediatric Oncology, and at the Children’s Hospital, Boston. She is also an associate professor of psychology in the department of psychiatry at the Harvard Medical School, Boston. For more than 30 years, Dr. Patenaude has worked with patients and family members affected by cancer and other life-threatening illnesses. Her research focus is on pediatric cancer survivors and on the psychosocial impact of cancer genetic testing on individuals and families. Dr. Patenaude is the author of Genetic Testing for Cancer: Psychological Approaches to Helping Patients and Families (American Psychological Association Books, 2005).
Yuri Quintana focuses on developing innovative technologies that empower communities of professionals and consumers to collaborate on a worldwide basis. He is currently the Director for Global Health Informatics in the Division of Clinical Informatics, Beth Israel Deaconess Medical Center and Associate Professor in Medicine at Harvard Medical School. Yuri does research and teaching on topics of global health information systems, global e-health applications, clinical informatics, consumer health informatics, mobile health systems, online learning systems, and serious games for health and wellness.
Ruma Rajbhandari, MD, MPH is an Associate Scientist in the Division of Global Health Equity and an Instructor at Harvard Medical School. Her global health focus is on health systems strengthening, human resources for health, quality of care and maternal and child health. Dr. Rajbhandari also serves as the Research Advisor for the Nick Simons Institute, a Nepal-based non-governmental organization whose mission is to innovate solutions in rural healthcare –through training and hospital support– and to advocate for their scale up with the government of Nepal. Her clinical practice is in the Division of Gastroenterology, Hepatology and Endoscopy where her primary interest is viral hepatitis, particularly hepatitis B, and general gastroenterology.
Dr. Rajbhandari is a graduate of the Doris and Howard Hiatt Global Health Equity Internal Medicine Residency Program at Brigham and Women’s Hospital. During residency, she divided her time between Boston and rural clinics and small district hospitals in the impoverished areas of Lesotho, Rwanda and Nepal. While in Nepal, she worked with the Nick Simons Institute and Possible. Currently, she also serves on Possible’s Advisory Board.
Dr. Rajbhandari earned her bachelor’s degree from Yale University, her MD from Harvard Medical School and her MPH from Harvard School of Public Health. She has also completed a fellowship in Gastroenterology and Hepatology at Massachusetts General Hospital, and earned a diploma in Tropical Medicine and Hygiene from the Gorgas Memorial Institute in Lima, Peru.
Gene Richardson collaborates on grants and projects related to his research on epidemic disease prevention and containment in sub-Saharan Africa. As a physician-anthropologist, Dr. Richardson helps bring the tools of social science to bear on Ariadne faculty collaborations.
Raffaella Sadun, an Ariadne Labs SPARK grantee, is focusing her research at Ariadne on the relationship between economics of productivity, management, and organizational change in hospitals. She collaborates with Dr. Alex Haynes, Associate Director of the Safe Surgery Program, on several projects developing methods to measure the quality of health system management, its effect on patient outcomes, and the design and implementation of management improvement programs.
Lipika Samal is a co-SPARK grantee of Ariadne Labs with Associate Faculty Dr. Joseph Jacobson. Their work is focused on improving cancer care delivery. Dr. Samal also researches the use of the electronic health record to improve chronic disease management and care coordination. She is funded by the National Institutes of Health under a career development award to design and evaluate a clinical decision support system for chronic kidney disease.
Justin Sanders serves as the clinical lead for a project focusing on disparities in care of the seriously ill, as well as a project focusing on the implementation of the Serious Illness Care Program internationally. He plays a key role in the Serious Illness Care Program at Ariadne Labs to develop and evaluate a standardized approach for promoting clinicians to conduct discussions about end-of-life values and goals with seriously ill patients and their families. He was recognized in 2016 as an emerging leader in the field of Palliative Care with a Sojourns Scholar Leadership Award from the Cambia Health Foundation.
Ryan Schwarz, as the chief operating officer of Possible, leads and oversees all aspects of Possible’s integrated health care model, including operations, logistics, and health care services throughout Nepal. Prior to his work with Possible, Dr. Schwarz worked with other health and development organizations in the USA, South Africa, Botswana, Ghana, and East Timor. His research focuses upon innovative health care models in both developing and developed countries.
Dan Schwarz, as the chief medical officer of Possible, oversees the development and delivery of hospital-based and community-based health care throughout rural Nepal. Prior to his work with Possible, he has worked for Partners In Health in multiple countries. At Ariadne, he collaborates with the Primary Health Care team, with a particular focus on the Primary Health Care Performance Initiative.
Dan Schwarz MD, MPH is the Associate Director of Primary Health Care at Ariadne Labs.
Dan brings to the team over a decade of global experience in facility- and community-based healthcare delivery. Prior to joining Ariadne Labs, Dan served as the Executive Director and then Chief Medical Officer for Possible Health (www.possiblehealth.org), which works in an innovative public-private partnership with the Nepali Ministry of Health providing integrated community and facility-based health care for nearly 250,000 residents in rural Nepal.
Katherine Semrau, as the Director of the BetterBirth Program at Ariadne Labs, oversees the research and execution of BetterBirth, a randomized control trial in Uttar, Pradesh aimed at improving the uptake of essential birth practices and reducing neonatal and maternal morbidity and mortality. Her previous work focused on prevention of maternal and child mortality and the prevention of mother-to-child transmission of HIV.
Neel Shah directs the Delivery Decisions Initiative (DDI) at Ariadne Labs, which aims to reduce suffering from overuse of medical interventions. Dr. Shah’s team is currently designing and testing a solution to the global pandemic of unnecessary c-sections. DDI has ongoing collaborations with architects at the MASS Design Group, mobile technology entrepreneurs at Ovia Health, epidemiologists at the Danish National Patient Registry, and system engineers at the Massachusetts Institute of Technology.
Mark Shrime serves as the Research Director at the Program in Global Surgery and Social Change at Harvard Medical School. He has collaborated with Ariadne Labs as part of the Lancet Commission on Global Health and is an active participant in Ariadne Labs’ Innovation meetings.
Brian Skotko’s research focuses on children with cognitive and developmental disabilities. He is currently developing an online platform to deliver clinical care to patients with Down syndrome.
Douglas S. Smink, MD, MPH is an Associate Professor in Surgery at Harvard Medical School and a minimally invasive general surgeon at Brigham and Women’s Hospital. Dr. Smink is the program director of the general surgery residency at Brigham and Women’s and the associate chair of education for the BWH Department of Surgery. He is the editor-in-chief of the Journal of Surgical Education. Dr. Smink’s research focuses on resident and faculty education through coaching and simulation, studying how to teach communication, leadership, and decision-making to surgeons and surgical teams.
Joshua Sparrow is actively exploring two possible collaborations with Ariadne Labs: one with Dr. Katherine Semrau’s perinatal work as part of the BetterBirth Program, and one with the Serious Illness Care Program about using online simulation professional development tools for end of life health care provider and patient conversations.
Donna Spiegelman is one of the few people in the world with a joint doctorate in Biostatistics and Epidemiology. As a result, she can freely speak the languages of both disciplines, and switch between the two cultures, playing the role of interlocutor for either. She is the statistician for the Nurses’ Health Study 2, the Health Professionals Follow-up Study, the Pooling Project of Prospective Studies of Diet and Cancer in Men and Women, the Harvard PEPFAR Dar es Salaam site, Trials of Vitamins in Dar es Salaam, and the multitude of projects spawned by these efforts. Her research is motivated by problems which arise in epidemiology and require biostatistical solutions. Dr. Spiegelman’s website is one of the most visited at the Harvard T.H. Chan School of Public Health (HSPH), because it contains much user-friendly well-documented freeware implementing non-standard methods useful in epidemiologic research. Dr. Spiegelman’s most recent interest has been to work with various departments in an interdisciplinary effort to greatly increase global public health efforts at HSPH. In particular, Dr. Spiegelman is interested in developing, testing, and implementing preventive interventions to abate global cancer, diabetes and cardiovascular disease epidemics and offers her expertise in monitoring and evaluation to this end. Dr. Spiegelman and her doctoral student collaborate with BetterBirth through examining the use of pilot data to understand programmatic changes and “learning-by-doing” models of implementation science.
Ariel Dora Stern’s research focuses on empirical analysis of health care markets, health care policy, and studying innovations in medical technology, pharmaceuticals, and health care delivery. She is interested in several topics related to the determinants of health care spending, regulatory policy, and the adoption of health technology, as well as the role of digitalization in products and services.
Rebecca Weintraub leads the Global Health Delivery Project, generating public goods for professionals delivering value based health care. This includes the Cases in Global Health Delivery (GHD), the first case collection offered at no cost with Harvard Business Publishing. In 2009, Weintraub launched a pilot program with UpToDate (UTD) to grant free subscriptions to UpToDate content to physicians, nurses, and other health workers caring for vulnerable populations. Today providers in 116 countries access this evidence based clinical resource. In addition, GHD has been researching the impact of UTD on medical students in sub-Saharan Africa. She is a co-director of our Ariadne Labs’ Innovation meetings and an active member of our Associate Faculty working group.
Roger Weiss served on the Ariadne Labs team that developed a physician checklist for better prescribing of opioids for people with chronic pain in order to create the proper balance of providing adequate pain treatment while reducing the risk of misuse and overdose. Developed for the Centers for Disease Control and Prevention, the tool guides primary care providers in a strategy that involves setting explicit goals for prescriptions, starting with brief trials first, stopping use when improvement in patient function with chronic pain is not achieved, and enabling regular reassessment. This checklist has rapidly entered wide use.
Chris Wong-Quiles collaborates with Ariadne Labs project “Making it Easier to Care for a Central Line at Home.” The project aims to reduce ambulatory CLABSI (Central Line Associated Bloodstream Infections) in pediatric hematology-oncology patients. They are doing this by developing a knowledge and skill development program that ensures that all caregivers in the home adhere to standardized care bundle and feel confident performing line care.
Zayed Yasin is the Assistant Director of the Division of International Collaborations in the Department of Emergency Medicine at the Brigham & Women’s Hospital. Dr. Yasin focuses on the intersection between Population Health and Acute Care Systems, and is currently working on projects to improve emergency care systems in Sweden and India.
Steven Yule is a leading academic psychologist and internationally recognized for his research on non-technical skills and patient safety in surgery. Most notably, he was one of the pioneers of the ‘Non-Technical Skills for Surgeons’ behavior observation system, which is now being implemented for surgical education and research in North America, Europe, Australia, Africa and Asia. Dr. Yule has authored several seminal manuscripts on non-technical skills, edited the first surgical textbook on the topic, and leads a research laboratory dedicated to advancing the field. His current research focuses on the relationship between clinicians’ behavior and patient outcomes, use of technology to automate surgical team assessment, and developing simulation-based support for astronauts to manage medical events on deep space missions. He is vice chair of the American College of Surgeons committee on non-technical skills and education chair of Association for Academic Surgery.
Michael Zalis serves as the chief medical officer of QPID Health, a medical informatics company based in Boston, MA. He is a board certified Radiologist with extensive experience in abdominal imaging, interventional radiology, computer science, and clinical research. Dr. Zalis continues to serve part-time as a staff member of Massachusetts General Hospital and as an associate professor at Harvard Medical School. Clinically, he serves on the abdominal imaging and interventional radiology services at MGH. He also currently direct the program in CT Colonography (aka “Virtual Colonoscopy”) at Massachusetts General Hospital; CT Colonography is a non-invasive method for colon cancer screening.